BNET Industries
Last Fiscal Year Sales:$3.1M
- Public
- US
Dow Jones Description
Avitar is the leader in oral-based, rapid diagnostics. Oral fluid diagnostics includes the estimated $1.5 billion drugs-of-abuse testing market. Avitar's proprietary disposable drugs-of-abuse technology will change the way that drug testing is done worldwide. For example, the company's ORALscreen product enables random on-site drug testing without the need for medical personnel, bathroom facilities, or the embarrassment of supervised urine collection. ORALscreen can be used by virtually anyone, any time, in any workplace environment. In the estimated larger $25 billion in vitro diagnostics market, Avitar is investigating oral-fluid based diagnostic strategies for disease and clinical testing, such as tests for influenza, diabetes and pregnancy. Avitar continues to build and serve an impressive client list of corporations and institutions, which currently include the following world-class organizations; Ablest, ADM, C.R. Bard, Bashas, DelMonte, Johnson & Johnson, Kendall Company, Kimberly Clark, Marcus, NASA, Parsons, SaveMart, Six Flags, Target, and TJX.
Chairman and Chief Executive Officer
Peter P. PhildiusNumber of Employees 36
Peer Companies
NAICS Code Surgical Appliance and Supplies Manufacturing: 339113
News & Analysis
Filter by
avitar inc. - All News and Analysis
Interesting News For January 16, 2008.
M2 PRESSWIRE-16 January 2008-Financialbusinessnews.us: Interesting News For January 16, 2008C1994-2008 M2 COMMUNICATIONS LTD RDATE:16012008 Boston, MA - FinancialBusinessNews' "Companies Of Interest": Exact Energy Resources, Inc. (PINK SHEETS: EXER); 3PAR (NYSE: PAR); TapImmune Inc. (OTCBB: TPIM);...
Avitar Aims to Increase Its Share of $1.5B Diagnostic Market
CANTON, Mass. -- Avitar Inc. ("AVTI") (OTCBB:AVTI), manufacturers of nationally branded oral fluid testing diagnostic devices and customized polyurethane applications used in wound dressings, announced today that, because of a recent GAO study of the Department of Transportation urine-based testing procedures and their high rate of failures, the patented Avitar...
Morning Updates for Wednesday, September 13, 2006 - Featuring Medcom USA, Avitar, China Direct Trading, Collins Industries, and More.
M2 PRESSWIRE-13 September 2006-Stockguru.com: Morning Updates for Wednesday, September 13, 2006 - Featuring Medcom USA, Avitar, China Direct Trading, Collins Industries, and MoreC1994-2006 M2 COMMUNICATIONS LTD RDATE:13092006 Dallas, Texas, September 13, 2006 - StockGuru Pre-Market Updates for Wednesday include Medcom...
Price and Volume Alerts for Wednesday August 16, 2006 - Featuring Windswept Environmental Group , REGI U.S., Global Energy Resources , Hanover Direct and More.
M2 PRESSWIRE-16 August 2006-Stockguru.com: Price and Volume Alerts for Wednesday August 16, 2006 - Featuring Windswept Environmental Group , REGI U.S., Global Energy Resources , Hanover Direct and MoreC1994-2006 M2 COMMUNICATIONS LTD RDATE:16082006 Dallas, Texas - StockGuru Price and Volume Alerts...
Charles R. McCarthy, Jr. Elected to Avitar, Inc. Board of Directors
CANTON, Mass.--BUSINESS WIRE--Feb. 22, 1999--Avitar, Inc. (NASD OTC Bulletin Board:AVIT) today announced that Charles R. McCarthy, Jr. has been elected to the Board of Directors of the Company. Mr. McCarthy is a partner with the Washington, D.C. law firm of O'Connor & Hannan, L.L.P. and currently...
Avitar, Inc. Reports First Quarter Financial Results
CANTON, Mass.--BUSINESS WIRE--Feb. 12, 1999--Avitar, Inc. (NASD OTC Bulletin Board:AVIT) reported financial results for its first fiscal quarter, ended December 31, 1998. Revenues for the quarter increased 12% to $484,000 compared to $432,000 for the quarter ended December 31, 1997. Increased sales of wound dressing products were primarily responsible...
Avitar, Inc. Obtains $350,000 Credit Line From Silicon Valley Bank
CANTON, Mass.--BUSINESS WIRE--May 5, 1998--Avitar, Inc. (NASD OTC Bulletin Board:AVIT)Common Stock; today announced an expanded relationship with Silicon Valley Bank through the addition of a Revolving Line of Credit. Under this arrangement, Avitar can borrow up to $350,000. Previously, the Company's borrowing was limited to the financing of certain accounts...
Avitar, Inc. Grants License to Manufacture and Market Dental Material Dispensing Device
CANTON, Mass.--BUSINESS WIRE--April 14, 1998-- Notes Substantial Year Over Year Sales Growth Continuing Avitar, Inc. (NASD OTC Bulletin Board: AVIT) today announced that it has granted an exclusive license for the manufacturing and marketing of Avitar's patented Dental Material Dispensing Devices and Consumable Cartridges...
Avitar, Inc. Extends Expiration Date And Reduces Exercise Price For Redeemable Warrants
CANTON, Mass.--BUSINESS WIRE--April 14, 1997--Avitar, Inc. ("the Company") [Nasdaq SmallCap Market:AVIT Common Stock; AVITW Redeemable Warrants] today announced that it has extended the expiration date of its Redeemable Warrants from April 30, 1997 to June 30, 1997. In addition, the Company announced that the Redeemable Warrant exercise price has...
Avitar, Inc. in preliminary pact with Trinity Biotech PLC
CANTON, MA--BUSINESS WIRE--March 31, 1997--Avitar, Inc. (Nasdaq SmallCap Market:AVIT Common Stock; AVITW Redeemable Warrants) today announced the signing of a preliminary agreement with Trinity Biotech plc (Nasdaq SmallCap Market:TRIBY) of Dublin, Ireland. Pursuant to the preliminary pact, Trinity will, over the next 60 days, evaluate the performance...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Douglas W. Scott | President and Chief Operating Officer, Director |
| Jay C Leatherman | Vice President, Chief Financial Officer Andsecretary |
| David A. Greaves | Vice President of Sales |
| Peter N. Cholakis | Vice President of Marketing |
| Richard Anderson | Vice President of Research & Development |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Peter P. Phildius | Chairman and Chief Executive Officer |
| Charles R. McCarthy | Board of Directors |
| Neil R. Gordon | Board of Directors |
Mr. Phildius has been Chairman of the Company's Board of Directors since October 1990 and Chief Executive Officer since July 1996. He has been a general partner in Phildius, Kenyon & Scott ("PK&S") since the firm's founding in 1985. Prior to 1985, Mr. Phildius was an independent consultant and Chairman and co-founder of Nutritional Management, Inc., a company that operates weight loss clinics (1983 - 1985), President and Chief Operating Officer of Delmed, Inc., a medical products company (1982 - 1983), President and Chief Operating Officer of National Medical Care, Inc., a dialysis and medical products company (1979 - 1981), and held a variety of senior management positions with Baxter Laboratories Inc. ("Baxter"), a hospital supply company and the predecessor of Baxter Healthcare Corporation. During the last eight years of his 18 year career at Baxter (1961 - 1979), Mr. Phildius was Group Vice President and President of the Parenteral Division, President of the Artificial Organs Division and President of the Fenwal Division.
| Organization | Position | Status |
|---|---|---|
| Avitar, Inc. | Chairman and Chief Executive Officer | Current |
| Avitar Technologies Inc. | CEO | Current |
| Vasca, Inc. | Current | |
| NxStage Medical, Inc. | Board of Directors | Current |
| Avitar, Inc. | Chairman and Chief, Executive Officer (Principal Executive Officer) | Current |
Mr. Scott has been the Chief Operating Officer since July 1996, was the Chief Executive Officer from August 1989 until July 1996 and has been a director of the Company since August 1989. Mr. Scott has been a general partner in PK&S since its founding in 1985. Prior to 1985, Mr. Scott was Executive Vice President of Nutritional Management, Inc. (1983 - 1985); Senior Vice President, Operations of Delmed, Inc. (1982 - 1983); Vice President, Quality Assurance of Frito-Lay, Inc., a consumer products company (1980 - 1982); and held several senior positions at Baxter from 1970 - 1980. The last two of these senior positions at Baxter were General Manager of the Vicra Division and General Manager of Irish Operations. Mr. Scott is also a director of Candela Corporation, a publicly-traded company in the business of manufacturing and marketing medical lasers. Mr. Scott received an M.B.A. from Harvard Business School.
| Organization | Position | Status |
|---|---|---|
| Avitar, Inc. | President and Chief Operating Officer, Director | Current |
| Candela Corporation | Board of Directors | Current |
| Avitar, Inc. | Chief Executive Officer | Former |
| Avitar, Inc. | Chief Operating Officer | Former |
| PepsiCo, Inc. | Vice President, Quality Assurance | Former |
| Frito-Lay, Inc. | Vice President | Former |
| Avitar, Inc. | Director | Former |
Jay C. Leatherman, Jr. , Chief Financial Officer: Mr. Leatherman has been Chief Financial Officer of the Company since October 1992. He has over 20 years experience in financial management in the healthcare field. Prior to joining Avitar, he was responsible for the financial, management information services and business development functions for a continuing care retirement community and management services company.
| Organization | Position | Status |
|---|---|---|
| Avitar, Inc. | Vice President, Chief Financial Officer Andsecretary | Current |
| Avitar, Inc. | Board of Directors | Current |
| Park Corp. | Chief Financial Officer | Former |
| Park Corp. | Vice President | Former |
| University of Hawaii | Bachelor's Degree In Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| Avitar, Inc. | Vice President of Sales | Current |
Peter N. Cholakis, Vice President of Marketing: Mr. Cholakis has over 20 years of senior marketing experience. He will lead Avitar's marketing function in penetrating the $1.5 billion drugs-of-abuse market with its point-of-care oral fluid drugs-of-abuse test, ORALscreen. Before joining Avitar, Peter Cholakis worked for VFA, a Boston-based enterprise software and services firm as Vice President of Marketing. Prior to that he also held key marketing and sales positions in the high tech product and consultative service markets.
| Organization | Position | Status |
|---|---|---|
| Avitar, Inc. | Vice President of Marketing | Current |
| Vfa | Former |
| Organization | Position | Status |
|---|---|---|
| Avitar, Inc. | Vice President of Research & Development | Current |
| Biosite Diagnostic Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| Avitar, Inc. | Board of Directors | Current |
| District of Columbia, LLC | Blue Sky Securities Commissioner | Former |
Neil R. Gordon, chief financial officer, began his career with the accounting firm of Haskins & Sells in 1969 and served as director, finance and accounting, of Empire of Carolina, Inc., from 1979 until 1982. He was then associated with Centronics Data Computer Corp., a computer peripherals manufacturer, and Ekco Group, Inc., a leading consumer products manufacturer and marketer, for fourteen years, including eight years as the company's treasurer, before establishing N.R. Gordon & Company, a financial services consulting firm, in 1995. Mr. Gordon serves on the board of directors of Avitar, Inc., and Datameg Corporation, as chief financial officer of Decent Energy, Inc., operator of the Cambridge Clean Energy Incubator, on the board of directors and as treasurer of Official Software, Inc., and as an advisor to a number of emerging companies. Mr. Gordon was an advisor to Case Shiller Weiss, Inc., from 1998 until its acquisition by Fiserv, Inc. He holds a BS in accounting from The Pennsylvania State University.
| Organization | Position | Status |
|---|---|---|
| Index Capital Advisors, LLC | Chief Financial Officer | Current |
| The Andover Historical Society | Director and Treasurer | Current |
| Datameg Corp | Board of Directors | Current |
| Avitar, Inc. | Board of Directors | Current |
| The Andover Historical Society | Treasurer | Current |
| Official Software, LLC | Treasurer | Current |
| Redchip Companies, Inc. | Director | Current |
| Association for Corporate Growth | Member | Current |
| Association for Corporate Growth | Member | Current |
| National Association of Corporate Directors | Member | Current |
| N.R. Gordon & Company | President | Former |
| Carolina LLC | Director, Finance | Former |
| Avitar, Inc. | Advisor | Former |
| N.R. Gordon & Company | Treasurer | Former |
| The Pennsylvania State University | Bachelor of Science Degree | Former |
Industry Transcripts by Seeking Alpha
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
-
Sunrise Senior Living Inc Q3 2009 Earnings Call Transcript
on Nov 09, 2009about SRZ
-
Alphatec Holdings, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about ATEC
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes


